Alpha-1 Antitrypsin Deficiency (AATD)
Open Clinical Trials

Takeda TAK-999-3001

The main aim of this study is to learn if fazirsiran reduces liver scarring (fibrosis) compared to placebo. Other aims are to learn if fazirsiran slows down…

Investigator
Virginia C Clark
Protocol ID
NCT05677971
Ages
18 Years – 75 Years
Sexes
All
Location
Gainesville